Daniel Koller
Chief Investment Officer at BB BIOTECH AG
Profile
Dr. Daniel Koller is a Head BB Biotech at Bellevue Asset Management AG and a Head-Investment Management at BB Biotech AG. He joined Bellevue Asset Management in 2004 and since 2010 he heads the management of BB Biotech AG. He was previously employed as Head-Compliance by Oz Holding AG, Private Equity Investor by Equity4life AG, an Equity Analyst by UBS Warburg, Inc., Auditor by Ernst & Young AG, and a Member-Management Board by Patrimonium Swiss Real Estate Fund. Dr. Koller holds a Master's degree in Biochemistry from the Swiss Federal Institute of Technology (ETH) Zurich and a Ph.D. in Biotechnology from the Swiss Federal Institute of Technology (ETH) Zurich and Cytos Biotechnology Ltd. Zurich.
Daniel Koller active positions
| Companies | Position | Start |
|---|---|---|
| BB BIOTECH AG | Chief Investment Officer | 2003-12-31 |
Bellevue Asset Management AG
 Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Head-Equity Investments | 2009-12-31 |
Former positions of Daniel Koller
| Companies | Position | End |
|---|---|---|
| BELLEVUE GROUP AG | Director of Finance/CFO | 2019-02-27 |
| VALARTIS GROUP AG | Compliance Officer | 2004-12-31 |
| Equity4life AG | Corporate Officer/Principal | 2003-12-31 |
Ernst & Young AG
 Ernst & Young AG Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young AG is a Swiss company that provides accounting services. The private company is based in Zurich, Switzerland. | Corporate Officer/Principal | 2003-12-31 |
| UBS Warburg, Inc. | Analyst-Equity | 2000-12-30 |
Training of Daniel Koller
| Swiss Federal Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BB BIOTECH AG | Finance |
| VALARTIS GROUP AG | Finance |
| BELLEVUE GROUP AG | Finance |
| Private companies | 5 |
|---|---|
Bellevue Asset Management AG
Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Finance |
| Equity4life AG | Miscellaneous |
Ernst & Young AG
Ernst & Young AG Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young AG is a Swiss company that provides accounting services. The private company is based in Zurich, Switzerland. | Commercial Services |
| UBS Warburg, Inc. | |
Patrimonium Swiss Real Estate Fund
 Patrimonium Swiss Real Estate Fund Investment Trusts/Mutual FundsMiscellaneous Patrimonium Swiss Real Estate Fund operates as a closed-end investment fund. It invests in residential and mixed properties with a focus on residential properties in the moderate-rent segment, mainly in the Lake Geneva region and the Fribourg, Bern, Baser and Zug axis. The company was founded on November 20, 2007 and is headquartered in Crissier, Switzerland. | Miscellaneous |
- Stock Market
- Insiders
- Daniel Koller
